• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA干扰介导的CD47下调通过激活大鼠模型中的内皮型一氧化氮合酶来预防缺血/再灌注诱导的心肌损伤。

RNAi-Mediated Down-Regulation of CD47 Protects against Ischemia/Reperfusion-Induced Myocardial Damage via Activation of eNOS in a Rat Model.

作者信息

Wang Hui-Bo, Yang Jun, Ding Jia-Wang, Chen Li-Hua, Li Song, Liu Xiao-Wen, Yang Chao-Jun, Fan Zhi-Xin, Yang Jian

机构信息

Department of Cardiology, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, China.

出版信息

Cell Physiol Biochem. 2016;40(5):1163-1174. doi: 10.1159/000453170. Epub 2016 Dec 14.

DOI:10.1159/000453170
PMID:27960187
Abstract

BACKGROUND/AIMS: Oxidative stress is strongly implicated in the pathogenesis of myocardial damage caused by ischemia reperfusion (I/R). Previous studies have confirmed that cardiac CD47 drives left ventricular heart failure. However, the role for CD47 in myocardial I/R injury (MIRI) has not previously been proposed. This study was designed to investigate whether down-regulation of CD47 using RNA interference (RNAi) technology can relieve inhibition of nitric oxide signaling and attenuate myocardial damage in a rat model of I/R.

METHODS

Male Sprague-Dawley rats (n = 40) were randomly allocated to four groups and pre-treated either with saline (Sham and I/R groups), or adenovirus expressing either control (Ad-EGFP-N) or CD47-targeting (Ad-EGFP-CD47) RNAi. After four days, the rat MIRI model was established by occluding the left anterior descending coronary artery for 30 min, followed by reperfusion for 3 h. Heart tissue was harvested and assessed by immunohistochemistry, western blot, and quantitative RT-PCR. Outcome measures included infarct size, myocardial enzyme (creatine kinase, creatine kinase-MB, and lactate dehydrogenase) levels in serum, markers of oxidative stress, and morphological changes to the myocardium.

RESULTS

Delivery of Ad-EGFP-CD47 RNAi into the myocardium remarkably decreased CD47 expression levels. Down-regulation of CD47 was significantly associated with reduced infarct size and serum levels of myocardial enzymes, increased activity of endothelial nitric oxide synthase, increased levels of nitric oxide, and decreased levels of oxidative stress.

CONCLUSION

These data indicate that down-regulation of CD47 exerts a protective effect against MIRI, which may be attributable to attenuation of oxidative stress via activation of the eNOS/NO signaling pathway.

摘要

背景/目的:氧化应激与缺血再灌注(I/R)所致心肌损伤的发病机制密切相关。既往研究证实心脏CD47可导致左心室心力衰竭。然而,此前尚未有人提出CD47在心肌I/R损伤(MIRI)中的作用。本研究旨在探讨使用RNA干扰(RNAi)技术下调CD47是否可缓解一氧化氮信号传导的抑制,并减轻I/R大鼠模型中的心肌损伤。

方法

将40只雄性Sprague-Dawley大鼠随机分为四组,分别用生理盐水(假手术组和I/R组)、表达对照(Ad-EGFP-N)或靶向CD47的(Ad-EGFP-CD47)RNAi的腺病毒进行预处理。四天后,通过阻断左冠状动脉前降支30分钟,然后再灌注3小时,建立大鼠MIRI模型。采集心脏组织,通过免疫组织化学、蛋白质印迹和定量RT-PCR进行评估。观察指标包括梗死面积、血清中心肌酶(肌酸激酶、肌酸激酶同工酶MB和乳酸脱氢酶)水平、氧化应激标志物以及心肌的形态学变化。

结果

将Ad-EGFP-CD47 RNAi导入心肌可显著降低CD47表达水平。CD47的下调与梗死面积减小、心肌酶血清水平降低、内皮型一氧化氮合酶活性增加、一氧化氮水平升高以及氧化应激水平降低显著相关。

结论

这些数据表明,下调CD47对MIRI具有保护作用,这可能归因于通过激活eNOS/NO信号通路减轻氧化应激。

相似文献

1
RNAi-Mediated Down-Regulation of CD47 Protects against Ischemia/Reperfusion-Induced Myocardial Damage via Activation of eNOS in a Rat Model.RNA干扰介导的CD47下调通过激活大鼠模型中的内皮型一氧化氮合酶来预防缺血/再灌注诱导的心肌损伤。
Cell Physiol Biochem. 2016;40(5):1163-1174. doi: 10.1159/000453170. Epub 2016 Dec 14.
2
Down-Regulation of miR-327 Alleviates Ischemia/Reperfusion-Induced Myocardial Damage by Targeting RP105.miR-327的下调通过靶向RP105减轻缺血/再灌注诱导的心肌损伤。
Cell Physiol Biochem. 2018;49(3):1049-1063. doi: 10.1159/000493288. Epub 2018 Sep 7.
3
RP105 Protects Against Apoptosis in Ischemia/Reperfusion-Induced Myocardial Damage in Rats by Suppressing TLR4-Mediated Signaling Pathways.RP105通过抑制TLR4介导的信号通路保护大鼠缺血/再灌注诱导的心肌损伤中的细胞凋亡。
Cell Physiol Biochem. 2015;36(6):2137-48. doi: 10.1159/000430180. Epub 2015 Jul 21.
4
Protective Effects of Shenfu Injection against Myocardial Ischemia-Reperfusion Injury via Activation of eNOS in Rats.参附注射液通过激活大鼠内皮型一氧化氮合酶对心肌缺血再灌注损伤的保护作用
Biol Pharm Bull. 2018 Sep 1;41(9):1406-1413. doi: 10.1248/bpb.b18-00212. Epub 2018 Jun 16.
5
Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats.大豆异黄酮通过增加去卵巢大鼠的内皮型一氧化氮合酶和降低氧化应激来保护心肌缺血/再灌注损伤。
Oxid Med Cell Longev. 2016;2016:5057405. doi: 10.1155/2016/5057405. Epub 2016 Feb 1.
6
Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux.表没食子儿茶素没食子酸酯通过PI3K/Akt通路介导的细胞凋亡抑制和自噬流恢复,对心肌缺血/再灌注损伤发挥保护作用。
Int J Mol Med. 2016 Jul;38(1):328-36. doi: 10.3892/ijmm.2016.2615. Epub 2016 May 31.
7
Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats.麦冬皂苷D通过上调大鼠CYP2J3/EETs减轻心肌缺血-再灌注损伤
Cell Physiol Biochem. 2018;49(4):1646-1658. doi: 10.1159/000493500. Epub 2018 Sep 18.
8
Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.Clematichinenoside 可减轻体内和体外缺血/再灌注损伤引起的心肌梗死。
Planta Med. 2013 Sep;79(14):1289-97. doi: 10.1055/s-0033-1350671. Epub 2013 Aug 8.
9
Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.梓醇可减少过氧亚硝酸盐的形成,从而发挥对缺血/再灌注损伤的心脏保护作用。
Pharm Biol. 2013 Apr;51(4):463-73. doi: 10.3109/13880209.2012.740052. Epub 2013 Jan 22.
10
Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.阿利吉仑通过激活一氧化氮合酶信号通路来抑制血管紧张素原,从而预防自发性高血压大鼠心肌缺血/再灌注损伤。
J Am Heart Assoc. 2014 Jan 28;3(1):e000606. doi: 10.1161/JAHA.113.000606.

引用本文的文献

1
Green tea's secret weapon: a review on the protective effects of epigallocatechin-3-gallate against ischemia/reperfusion damage.绿茶的秘密武器:表没食子儿茶素-3-没食子酸酯对缺血/再灌注损伤保护作用的综述
Pharmacol Rep. 2025 Sep 5. doi: 10.1007/s43440-025-00781-y.
2
The value of CD47 and CAP1 levels in early diagnosis and MACE prediction for patients with non-ST-segment elevation myocardial infarction.CD47和CAP1水平在非ST段抬高型心肌梗死患者早期诊断及主要不良心血管事件预测中的价值
BMC Cardiovasc Disord. 2025 Jul 25;25(1):541. doi: 10.1186/s12872-025-04939-7.
3
Smooth muscle cell-specific CD47 deletion suppresses atherosclerosis.
平滑肌细胞特异性CD47缺失可抑制动脉粥样硬化。
Life Sci. 2025 Jan 15;361:123315. doi: 10.1016/j.lfs.2024.123315. Epub 2024 Dec 13.
4
CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils.CD47阻断增强了中性粒细胞对心脏细胞碎片的吞噬作用。
Int J Cardiol Heart Vasc. 2023 Sep 9;48:101269. doi: 10.1016/j.ijcha.2023.101269. eCollection 2023 Oct.
5
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.二十二碳六烯酸衍生的促解决脂质介质的潜在临床应用
Nutrients. 2023 Jul 26;15(15):3317. doi: 10.3390/nu15153317.
6
Pathways for Cardioprotection in Perspective: Focus on Remote Conditioning and Extracellular Vesicles.心脏保护途径展望:聚焦远程预处理与细胞外囊泡
Biology (Basel). 2023 Feb 14;12(2):308. doi: 10.3390/biology12020308.
7
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.心肾综合征中的生物标志物及对新型治疗方法的潜在见解
Front Cardiovasc Med. 2022 May 20;9:868658. doi: 10.3389/fcvm.2022.868658. eCollection 2022.
8
CD47 antibody protects mice from doxorubicin-induced myocardial damage by suppressing cardiomyocyte apoptosis.CD47抗体通过抑制心肌细胞凋亡保护小鼠免受阿霉素诱导的心肌损伤。
Exp Ther Med. 2022 May;23(5):350. doi: 10.3892/etm.2022.11277. Epub 2022 Mar 24.
9
Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences.青藤碱在心血管疾病中的潜在治疗作用及药理学证据
Front Cardiovasc Med. 2021 Oct 1;8:749113. doi: 10.3389/fcvm.2021.749113. eCollection 2021.
10
Targeting Glycogen Synthase Kinase 3 Beta Regulates CD47 Expression After Myocardial Infarction in Rats via the NF-κB Signaling Pathway.靶向糖原合酶激酶3β通过NF-κB信号通路调节大鼠心肌梗死后的CD47表达。
Front Pharmacol. 2021 Jul 19;12:662726. doi: 10.3389/fphar.2021.662726. eCollection 2021.